Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Genentech
 More »

  • Pharma Touting Phase II/III Wins in Run-Up to ASCO
    Squibb, Gilead Sciences, and Roche/Genentech are among those companies announcing ... Meantime, Roche's Genentech is reporting Phase III successes for its investigational drug ...
    5-16-2013
  • FDA Approves Roche EGFR Mutation CDx for NSCLC
    Tarceva, which is co-marketed by Genentech, received initial FDA approval in November 2004 for the treatment of patients with locally advanced or metastatic NSCLC after failure of ...
    5-15-2013
  • Companion Diagnostics: 52 Pick-Up
    ... Financial terms: Not disclosed. Astellas Pharma and Roche (Genentech) Submission announced ... Tarceva is a kinase inhibitor drug co-developed by OSI and Genentech, and initially ...
    5-9-2013
  • BMS Partners Again with Ambrx, in Up-to-$112M-and-Up ADC Collaboration
    Additional terms were not disclosed. Ambrx and BMS are among companies looking to develop ADCs: The list includes Roche (Genentech)'s Kadcyla, approved in February for breast ...
    5-3-2013
  • New Study Shows Where to Start Your Start-Up
    ... We are often asked, "Where's the next Genentech coming from?" It certainly isn't going to spring into existence just because that's seen as a good outcome. It is, however, much ...
    5-1-2013
  • Hormone Holds Promise for Replacing Insulin Injections
    ... CHDI, Genentech, MedImmune/AstraZeneca, and Ono Pharmaceutical. On Monday, Evotec said it was extending by three additional years its alliance with Roche's Genentech ...
    4-26-2013
  • GEN | Biolinks
    ... de Agricultura Gallus Biopharmaceuticals GE Healthcare Life Sciences Gene Link Genentech GenTech Scientific Genzyme Georgetown University Georgia Bio Georgia Department of ...
  • Biosimilars: 10 Drugs to Watch
    ... Fujifilm Kyowa Kirin Biologics, to develop a biosimilar version of Avastin (Roche / Genentech) for cancer indications Lispro: Biocon and Mylan announed a strategic collaboration ...
    4-22-2013
  • People in the News
    John LaMattina, Ph.D. , joined Ziarco as strategic advisor. Tom Klein XOMA added Tom Klein as CCO. He joined XOMA from Genentech, where he was vp, business unit head virology and ...
    4-15-2013
  • AACR Rally for Medical Research
    He once served as the chief scientific officer at Genentech. He also sees the funding cuts to NIH research as destructive. But he added another perspective to the funding problem. ...
    4-8-2013
  • Astellas, Ambrx Launch Up-To-$300M ADC Partnership
    Ambrx is among biotechs that have focused on developing ADCs, hoping to follow in the successful footsteps of drug developers like Roche's Genentech unit and ImmunoGen, which won ...
    4-5-2013
  • Top 20 Best-Selling Drugs Approved and Launched During 2012
    ... (CHF 29 million) 10 Marketer(s): Roche (Genentech) Indication(s): Advanced basal cell ... (CHF 56 million) 15 Marketer(s): Roche (Genentech) Indication(s): First-line treatment of ...
    4-4-2013
  • Direct DNA Sequencing Using Nanopore Sensors
    ... The Breakthrough Prize in Life Sciences, founded by the chairman of Apple and Genentech Art Levinson, Google co-founder Sergey Brin, 23andMe founder Anne Wojcicki, Facebook founder ...
    4-1-2013
  • Biosimilars: Not So Far So Fast
    Regulatory issues are among the hurdles that are slowing down biosimilar production. Until very recently, biosimilars were expected to become an increasingly large part of the ...
    3-15-2013
  • Zapping Pathological Proteins in Alzheimer's
    ... antibody, to Genentech for clinical development and commercialization. Preclinical studies show that crenezumab binds Abeta and clears it from the brain. Genentech is testing ...
    3-1-2013

  • Journal Articles

  • Neoadjuvant Immunotherapy Enhances Radiosensitivity Through Natural...
    Chau-Hwa Chi, Yu-Shan Wang, Chieh-Han Yang, Kwan-Hwa Chi
    Cancer Biotherapy and Radiopharmaceuticals
    The radiosensitization effect of combined CpG and Herceptin® (Genentech, Inc., South San Francisco, CA) (CpG/Herceptin), given before or after radiation, was evaluated by using a ...
  • Effect of Antilymphoma Antibody, 131 I-Lym-1, on Peripheral Blood...
    Orazio Schillaci, Gerald L. DeNardo, Sally J. DeNardo, Desiree S. Goldstein, Linda A. Kroger, Robert T. O'Donnell, Kathleen R. Lamborn
    Cancer Biotherapy and Radiopharmaceuticals
    ABSTRACT Anti-CD20 monoclonal antibodies (mAbs), unlabeled rituximab (Rituxan®, Biogen Idec Inc., Cambridge, MA; and Genentech Inc., South San Francisco, CA) or radiolabeled ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll